DMK PHARMACEUTICALS Corp: Nasdaq/NYSE listing notice — Nasdaq grants Adamis extension to June 26, 2023 to meet $1 bid price; reverse split required if needed

DMK PHARMACEUTICALS Corp

Nasdaq Hearings Panel granted extension through June 26, 2023 to evidence compliance with $1.00 bid price rule.
Conditions include seeking shareholder approval for reverse stock split and effecting it if needed to achieve $1.00 bid for 10 consecutive days.
Company previously failed to comply by Dec 27, 2022 after two 180-day grace periods.
CEO mentions strategic and financing alternatives process announced in October 2022.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DMK PHARMACEUTICALS Corp received a nasdaq hearing update notice regarding minimum bid price (rules 5500(a)(2)).

Exchange: nasdaq
Notice: hearing update
Deficiency: minimum bid price
Rules: 5500(a)(2)

Exact text from the filing

February 21, 2023, Adamis Pharmaceuticals Corporation (“Adamis” or the “Company”) received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) had granted the Company’s request for continued listing on The Nasdaq Capital Market, subject to the Company evidencing compliance with all applicable criteria for continued listing, including the $1.00 bid price requirement set forth in Nasdaq Listing Rule 5500(a)(2) (the “Rule”), by no later than June 26, 2023 (the “Compliance Period”). The Company’s continued listing is subject to the Comp

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001387131-23-002294

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.